More importantly, high PD-L1 expression was significantly associated with worse overall survival, regardless of sex, age, tumor size, histology, site, surgical outcome and adjuvant treatment, thus envisaging that, similarly to other pediatric tumors, the PD-1/PD-L1 axis may represent a potential therapeutic target for the treatment of young STS patients [114]. Here, CD274 is linked to telomere syndrome.